Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

RedHill Biopharma Ltd. RDHL

Full chart Compare
Set alert

Price alert · RDHL

All alert types
0.42 USD -0.03 (-5.82%)

At closeNov 4, 2026, 8:38 AM EST

0.40 -0.02 -3.82%

Pre-market · Nov 4, 8:38 AM ET

0.4101 Day range 0.4559
0.38 52-week range 1.60
YTD
-59.62%
1 year
-61.49%

Financial health

Altman Z-Score

-24.13 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -7.6×
FY 2016: -9.5×FY 2017: -4.0×FY 2018: -6.5×FY 2019: -8.7×FY 2020: -8.1×FY 2021: -2.6×FY 2022: -0.2×FY 2023: 0.8×FY 2024: -0.9×FY 2025: -7.6×
FY 2016 5y median -0.9× FY 2025
P/S 11.4×
FY 2016: 2662×FY 2017: 45.3×FY 2018: 30.7×FY 2019: 57.3×FY 2020: 9.1×FY 2021: 2.8×FY 2022: 0.3×FY 2023: 2.9×FY 2024: 1.9×FY 2025: 11.4×
FY 2016 5y median 2.8× FY 2025
P/B 0.8×
FY 2016: 4.3×FY 2017: 4.0×FY 2018: 5.0×FY 2019: 6.0×FY 2020: 42.5×FY 2021: 27.1×FY 2022: -0.4×FY 2023: 9.1×FY 2024: -3.3×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
P/FCF -0.3×
FY 2016: -9.5×FY 2017: -4.0×FY 2018: -7.4×FY 2019: -8.8×FY 2020: -5.8×FY 2021: -3.7×FY 2022: -0.6×FY 2023: -0.5×FY 2024: -1.6×FY 2025: -0.3×
FY 2016 5y median -0.6× FY 2025
EV/EBITDA -0.0×
FY 2016: -7.1×FY 2017: -3.6×FY 2018: -5.9×FY 2019: -8.2×FY 2020: -11.8×FY 2021: -4.7×FY 2022: -5.4×FY 2023: 0.6×FY 2024: -1.5×FY 2025: -0.0×
FY 2016 5y median -1.5× FY 2025
EV/Sales 1.2×
FY 2016: 2129×FY 2017: 41.2×FY 2018: 27.2×FY 2019: 53.3×FY 2020: 10.0×FY 2021: 3.5×FY 2022: 1.9×FY 2023: 2.2×FY 2024: 1.4×FY 2025: 1.2×
FY 2016 5y median 1.9× FY 2025
FCF Yield -296.7%
FY 2016: -10.6%FY 2017: -25.3%FY 2018: -13.5%FY 2019: -11.4%FY 2020: -17.4%FY 2021: -27.1%FY 2022: -169.1%FY 2023: -189.4%FY 2024: -61.3%FY 2025: -296.7%
FY 2016 5y median -169.1% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: -30140.6%FY 2017: 46.9%FY 2018: 66.1%FY 2019: 64.1%FY 2020: 42.7%FY 2021: 42.4%FY 2022: 46.1%FY 2023: 47.0%FY 2024: 60.3%FY 2025: 100.0%
FY 2016 5y median 47.0% FY 2025
Operating Margin -2765.4%
FY 2016: -30240.6%FY 2017: -1297.0%FY 2018: -470.5%FY 2019: -686.7%FY 2020: -99.0%FY 2021: -94.6%FY 2022: -69.3%FY 2023: 193.4%FY 2024: -181.7%FY 2025: -2765.4%
FY 2016 5y median -94.6% FY 2025
Net Margin -150.0%
FY 2016: -29079.2%FY 2017: -1136.6%FY 2018: -464.4%FY 2019: -672.5%FY 2020: -118.4%FY 2021: -114.0%FY 2022: -116.0%FY 2023: 366.2%FY 2024: -102.8%FY 2025: -150.0%
FY 2016 5y median -114.0% FY 2025
ROE -10.1%
FY 2016: -46.8%FY 2017: -101.1%FY 2018: -75.8%FY 2019: -70.5%FY 2020: -549.4%FY 2021: -1101.3%FY 2022: 148.1%FY 2023: 1155.9%FY 2024: 176.6%FY 2025: -10.1%
FY 2016 5y median 148.1% FY 2025
ROIC -125.7%
FY 2016: -44.4%FY 2017: -114.2%FY 2018: -75.6%FY 2019: -67.2%FY 2020: -58.6%FY 2021: -80.1%FY 2022: -55.2%FY 2023: 279.3%FY 2024: 381.8%FY 2025: -125.7%
FY 2016 5y median -55.2% FY 2025
ROA -1.7%
FY 2016: -39.6%FY 2017: -79.4%FY 2018: -62.2%FY 2019: -57.1%FY 2020: -42.3%FY 2021: -53.9%FY 2022: -45.1%FY 2023: 103.8%FY 2024: -45.8%FY 2025: -1.7%
FY 2016 5y median -45.1% FY 2025

Growth (YoY)

Revenue -96.4%
FY 2016: 3266.7%FY 2017: 3867.3%FY 2018: 108.6%FY 2019: -24.7%FY 2020: 923.0%FY 2021: 33.2%FY 2022: -27.9%FY 2023: -89.4%FY 2024: 23.2%FY 2025: -96.4%
FY 2016 FY 2025
Operating Income 45.9%
FY 2016: -38.8%FY 2017: -70.2%FY 2018: 24.3%FY 2019: -9.8%FY 2020: -47.4%FY 2021: -27.4%FY 2022: 47.2%FY 2023: 129.5%FY 2024: -215.7%FY 2025: 45.9%
FY 2016 FY 2025
EPS (diluted) 100.0%
FY 2016: -15.8%FY 2017: -18.2%FY 2018: 34.6%FY 2019: 17.6%FY 2020: -42.9%FY 2021: 0.0%FY 2022: 40.0%FY 2023: 107.7%FY 2024: -115.2%FY 2025: 100.0%
FY 2016 FY 2025
Free Cash Flow -3.0%
FY 2016: -45.8%FY 2017: -61.9%FY 2018: 24.9%FY 2019: -18.6%FY 2020: -149.9%FY 2021: 36.3%FY 2022: 54.9%FY 2023: -21.9%FY 2024: 73.8%FY 2025: -3.0%
FY 2016 FY 2025

Financial Health

Current Ratio 0.3×
FY 2016: 12.7×FY 2017: 4.4×FY 2018: 5.5×FY 2019: 5.0×FY 2020: 1.0×FY 2021: 1.1×FY 2022: 0.4×FY 2023: 0.8×FY 2024: 0.5×FY 2025: 0.3×
FY 2016 5y median 0.5× FY 2025
Quick Ratio 0.3×
FY 2016: 12.5×FY 2017: 4.3×FY 2018: 5.4×FY 2019: 4.8×FY 2020: 0.9×FY 2021: 0.9×FY 2022: 0.4×FY 2023: 0.6×FY 2024: 0.4×FY 2025: 0.3×
FY 2016 5y median 0.4× FY 2025
Debt / Equity 0.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 6.3×FY 2021: 9.9×FY 2022: -2.5×FY 2023: 0.6×FY 2024: -0.1×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 1.8×FY 2017: 0.4×FY 2018: 0.7×FY 2019: 0.6×FY 2020: -1.0×FY 2021: -0.9×FY 2022: -4.6×FY 2023: -0.2×FY 2024: 0.6×FY 2025: 0.4×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -416×
FY 2016: -4363×FY 2017: -675×FY 2018: -236×FY 2019: -98.3×FY 2020: -5.1×FY 2021: -4.9×FY 2022: -1.0×FY 2023: 34.4×FY 2024: -266×FY 2025: -416×
FY 2016 5y median -4.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31